Author

Richard Lee O'Neal

Observed names: R. O'Neal, Richard L O'Neal, Richard L. O’Neal, Richard O'Neal, Richard O’Neal

Institution: Prisma Health

Observed institutions: Prisma Health, University of Kentucky HealthCare, University of Kentucky, Markey Cancer Center

ORCID: 0000-0001-9081-1680

Observed ORCID: 0000-0001-9081-1680

OpenAlex ID: A5027645406

Resident Preferences for Program Director Role in Wellness Management

2018 · Russ C. Kolarik, Richard L. O’Neal, et al. · Journal of General Internal Medicine · 34

Disparities in prostate cancer survival in Appalachian Kentucky: a population-based study

2019 · Zin Myint, Richard O'Neal, et al. · Rural and Remote Health · 15

Challenges in Medicine: The Odyssey of a Patient with Isolated IgG4-Related Eosinophilic Angiocentric Fibrosis Presenting as a Locally Destructive Sinonasal Mass

2021 · Snigdha Nutalapati, Richard O’Neal, et al. · Case Reports in Rheumatology · 11

OA07.03 A Phase II Study of Frontline Rucaparib + Nivolumab in Platinum Sensitive ES SCLC: Interim Analysis

2021 · A. Chauhan, J. Kolesar, et al. · Journal of Thoracic Oncology · 5

“JUMPing into Diabetes Control”: A Group-Setting Self-Empowerment Lifestyle Intervention among Diabetes Patients

2020 · Sheena Henry, Lu Shi, et al. · Healthcare · 5

PEMDA-HN, an open-label, phase II, randomized controlled study of danvatirsen plus pembrolizumab compared to pembrolizumab alone in first-line recurrent and/or metastatic head and neck squamous cell carcinoma (RM HNSCC).

2024 · Marshall R. Posner, Deborah J.L. Wong, et al. · Journal of Clinical Oncology · 2

Rechallenging with immune checkpoint inhibition after a treatment-limiting immune-related adverse event.

2020 · Richard Lee O'Neal, Kandice Roberts, et al. · Journal of Clinical Oncology · 1

Immune-related adverse events for different age groups using the FDA Adverse Event Reporting System.

2019 · Zin Myint, Ayman Qasrawi, et al. · Journal of Clinical Oncology · 1

Applications for the MASCC Risk Index for Febrile Neutropenia in Patients with Hematologic Malignancy

2019 · Richard O'Neal, Kandice Roberts, et al. · Transplantation and Cellular Therapy · 1

AML-294: Predictors of Short-Term and Long-Term Mortality in Leukemia Patients with Neutropenic Fever

2020 · Quang Nguyen, Amitoj Gill, et al. · Clinical Lymphoma Myeloma & Leukemia

The impact of adjuvant therapy for non-metastatic thymic carcinoma: An analysis of the surveillance, epidemiology, and end results (SEER) database.

2020 · Richard Lee O'Neal, OIga Vsevolozhskaya, et al. · Journal of Clinical Oncology

Disparities in Plasma Cell Neoplasms in Kentucky, Appalachia and Other States: A Population Based Study

2019 · Ayman Qasrawi, Richard L O'Neal, et al. · Blood

Greenville health system (GHS) experience with risk reduction endocrine therapy for women diagnosed with breast lobular carcinoma in situ (LCIS).

2017 · Richard O'Neal, Wendy R. Cornett, et al. · Journal of Clinical Oncology

Works count: 13

Citation count: 75

H-index: 5

I10-index: 3